ARMI | BioFabUSA will be speaking at the 11th Annual Business of Regenerative Medicine: Innovation, Clinical Translation & Entrepreneurship Symposium.
ARMI Speakers will include:
Tom Bollenbach, Chief Technology Officer
The 11th annual Business of Regenerative Medicine: Innovation, Clinical Translation, and Entrepreneurship Symposium, a 2-day event with preceding evening reception and tour, will include lectures delivered by established entrepreneurs, industry and scientific leaders, panel discussions, networking events and more. It is attended by entrepreneurs, junior and senior scientists, business executives, investors and analysts, technology transfer and development personnel, managers in the government, non-profit and profit sectors.
The Symposium is hosted by the Center for Cellular Immunotherapies and the Institute for Regenerative Medicine at the University of Pennsylvania in partnership with Case Western Reserve University, the Harvard Stem Cell Institute, the Parker H. Petit for Institute Bioengineering and Bioscience at Georgia Tech, and the Centre for Commercialization of Regenerative Medicine.
The Stories of First In Class FDA Approved Gene Therapies Kymriah and Luxturna
Immune Cell Therapies: Where to Now?
Translating Regenerative Medicine
Regulatory and Ethical Foundation of Cellular and Tissue Based Therapies
Novel Applications of Mesenchymal Stromal Cells and Placental Derived Stem Cells
The Intersection of Engineering and Biology in the Creation of Novel Therapies
Operation of an Academic Cell Manufacturing Facility and Tech Transfer to Industry
Role of Academic Industry Government Consortia and Professional Societies
Intellectual Property and Licensing
Entrepreneurial Science and Commercialization